oh really - 15 million relenza doses , page-17

re: ousia's update Hi Biotians,

Do we really believe that with 5 GSK plants producing or going to produce Relenza very soon that they can only produce 15 million dosis????


For those who still not believe in those 5 GSK plants I will give the names again and you can all search the net and see that these plants are involved with making Relenza.

PRODUCTION FACTORIES FOR RELENZA


1 MELBOURNE (BORONIA) STARTING 2006

2 MONTROSE (SCOTLAND) PRODUCING

3 FRANCE PRODUCING

4 ULVERSTON (ENGLAND) PRODUCING

5 ZEBULON ( USA ) , NORTH CAROLINA
http://www.diversityworking.com/viewJob/?jobId=114412

6 INDIA CHIPLA 4% ROYALTY
http://www.mja.com.au/public/issues/184_01_020106/lok10852_fm.html

7 TAIWAN ITRI CAPABLE OF PRODUCING
ttp://www.taipeitimes.com/News/taiwan/archives/2005/12/23/2003285619/wiki

8 THAILAND (GENERIC VERSION PATENT NOT RESOLVED)
(FIRSTPRODUCTION OCTOBER 2006)
http://sify.com/finance/fullstory.php?id=13980957


Do we all realise the sales of Relenza that have been signed off so far???
Following I will once again publish the list of all the sales I know off by searching the internet.
Obviously there are many more which have not been reported.

Here follows the latest update of the sales that I know off.


RELENZA SALES Germany 1.7 Million Packs
Hong Kong 150 000 Packs
France 200 000 Packs
(Relenza sales announcements to the market) USA 84300 Packs (10% royalty)
USA Order details to be announced
Holland? Order details to be announced (1,25 million packs)
France 9 Million Packs (over 2 years)
Hong Kong 2 Million Packs (over 2 years)
Australia 1.8 Million Packs (10% royalty)
Singapore 50 000 packs
Greece 200 000 packs
Belgium 210 000 packs
Pharmacy sales 2 Million packs ???

TOTAL SALES RELENZA TO DATE 18 644 300 PACKS
SALES AT POTENTIAL APPROX. $30 PER PACK $559 329 000
BIOTA SHARE 7% ROYALTIES TO DATE $39,153 030.00
10% USA, AU,NZ,SA,IN


I also know that 3 Biota directors have put in more then $200,000 of their own money in buying more shares in Biota.
This was at the end of dec 2005 and they paid on the market around $1.48 per share.

You would think they should know what they are doing.

I believe that we are once again left in the dark by GSK for various reasons that those who have followed and researched Biota know all too well.

The figures speak for themselves and I stay upbeat about the furure direction of the shares in Biota.

Wait till we get some good results from Relenza in the field , Goverments will force GSK to produce more even if they themselves only want to sell their vaccines that has no proven protection against a mutating virus.

Just remember the game of keeping Relenza down has only just started and I still believe that GSK is going to loose this one.

A product like Relenza will at the end sell itself.
Not only will it sell itself but in a situation where human lives are at stake we can expect various governements around the world to force GSK to produce it.

Remember they were called to the white house once and they could be called back at any time if the situation arises.

jojo